Correlation Between Tonix Pharmaceuticals and Gelesis Holdings
Can any of the company-specific risk be diversified away by investing in both Tonix Pharmaceuticals and Gelesis Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tonix Pharmaceuticals and Gelesis Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tonix Pharmaceuticals Holding and Gelesis Holdings, you can compare the effects of market volatilities on Tonix Pharmaceuticals and Gelesis Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tonix Pharmaceuticals with a short position of Gelesis Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tonix Pharmaceuticals and Gelesis Holdings.
Diversification Opportunities for Tonix Pharmaceuticals and Gelesis Holdings
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Tonix and Gelesis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Tonix Pharmaceuticals Holding and Gelesis Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gelesis Holdings and Tonix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tonix Pharmaceuticals Holding are associated (or correlated) with Gelesis Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gelesis Holdings has no effect on the direction of Tonix Pharmaceuticals i.e., Tonix Pharmaceuticals and Gelesis Holdings go up and down completely randomly.
Pair Corralation between Tonix Pharmaceuticals and Gelesis Holdings
If you would invest 15.00 in Tonix Pharmaceuticals Holding on September 30, 2024 and sell it today you would earn a total of 19.00 from holding Tonix Pharmaceuticals Holding or generate 126.67% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Tonix Pharmaceuticals Holding vs. Gelesis Holdings
Performance |
Timeline |
Tonix Pharmaceuticals |
Gelesis Holdings |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Tonix Pharmaceuticals and Gelesis Holdings Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Tonix Pharmaceuticals and Gelesis Holdings
The main advantage of trading using opposite Tonix Pharmaceuticals and Gelesis Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tonix Pharmaceuticals position performs unexpectedly, Gelesis Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gelesis Holdings will offset losses from the drop in Gelesis Holdings' long position.Tonix Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | Tonix Pharmaceuticals vs. Palisade Bio | Tonix Pharmaceuticals vs. Ibio Inc | Tonix Pharmaceuticals vs. Jaguar Animal Health |
Gelesis Holdings vs. The Coca Cola | Gelesis Holdings vs. Molson Coors Brewing | Gelesis Holdings vs. FitLife Brands, Common | Gelesis Holdings vs. Sligro Food Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |